Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1AMLODIPINE AND OLMESARTAN MEDOXOMIL

02 1BENAZEPRIL HYDROCHLORIDE

03 1BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE

04 1CEFUROXIME AXETIL

05 9CLOPIDOGREL BISULFATE

06 1CYTOTEC

07 1DEFERASIROX

08 1LOTENSIN

09 2MISOPROSTOL

10 1OLMESARTAN MEDOXOMIL

11 1PLAVIX

12 1VALACYCLOVIR HYDROCHLORIDE

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

CLOPIDOGREL BISULFATE

Drug : PLAVIX

Dosage Form : TABLET; ORAL

Application Number : 20839

Country : US

Patented : No

Sanofi Company Banner

02

arrow
2024 ACI Convention
Not Confirmed

03

arrow
2024 ACI Convention
Not Confirmed

04

arrow
2024 ACI Convention
Not Confirmed

05

arrow
2024 ACI Convention
Not Confirmed

06

arrow
2024 ACI Convention
Not Confirmed

07

arrow
2024 ACI Convention
Not Confirmed

08

arrow
2024 ACI Convention
Not Confirmed

09

arrow
2024 ACI Convention
Not Confirmed

10

arrow
2024 ACI Convention
Not Confirmed